About Us
Our team brings proven leadership in healthcare, private equity, and operations, with a successful track record of building and scaling transformative platforms.
Neil Dugdale
Commercial leader with 25+ years driving pharmaceutical growth across European markets. Former CEO of Flynn Pharma and Interim Commercial Director at Rosemont Pharmaceuticals with global commercial responsibility. Previously served as VP & GM Northern Europe and UK & Ireland GM at Sobi, UK Country Lead at GenSight Biologics, and Director of Oncology at Merck Serono. Proven track record building and scaling commercial operations in rare diseases, oncology, and specialty therapeutics across UK, Ireland, Nordics, and Middle East.
Sean Roberts
General Counsel and Head of Corporate Affairs with 30+ years operating at board level in FTSE 50 companies. Led strategy, M&A, and joint ventures including the GlaxoWellcome and SmithKline Beecham merger, and creation of global joint ventures between GSK and both Novartis and Pfizer. Previously SVP General Counsel at GSK Consumer Healthcare and Chief Legal and Corporate Affairs Officer at Imperial Brands. Extensive expertise building legal and compliance frameworks in complex, regulated global pharma businesses.
Simon Egan
Strategic management and business development entrepreneur with 40+ years transforming complex business scenarios into actionable plans. Founder & CFO of Alverium Health, a contract biotech company with a unique approach to pharmaceutical commercialization. Previously Finance Director and Founding Partner at FleetEurope PLC, Partner at TISE Associates, and Senior Group Manager at Unilever. Extensive expertise in business strategy, M&A, financial management, and building sustainable organizations across healthcare and life sciences.
Ian Crouch
Strategic team builder with 18+ years guiding early-stage biotechs from concept to exit. Played pivotal roles in 10+ transitions including Synageva, Kite, GW Pharmaceuticals, Shire, and Intercept. Partners with CEOs, boards, and investors to design strategic resourcing plans, build executive teams, and orchestrate critical commercial and financial introductions. Deep cross-border experience across US, European, and emerging markets. Currently works with visionary founders developing breakthrough therapies, building leadership capacity for global scale and strategic transactions.
Lina Cogan
Pharmaceutical executive with 20+ years in business development, strategic sourcing, and commercial operations across APIs and drug manufacturing. Co-founder at CollaBio Healthcare leading strategic acquisition initiatives in EU. Previously Corporate Head of Business Development at ABA Chemicals, Senior Director Global Sourcing at LGM Pharma, and Director roles at Teva Pharmaceuticals managing $900M+ globally. Extensive expertise in transformation, market expansion, M&A, and optimizing procurement and supply chain operations.
Nick Plumeridge
Life science executive with 30+ years in global pharmaceutical business development and M&A. Former Royal Navy officer, subsequently held senior roles at Aventis, Serono, Takeda, Quintiles, Epirus, and mAbxience. Led major transactions including Nycomed and Valeant acquisitions, plus JV's and licensing deals across biologics and small molecules. Currently independent consultant focused on early-stage strategies, partnerships, and alliances for biotech startups and academic spin-outs across Europe, North America, Asia Pacific, and emerging markets.
Jamie Hawkes
Technical executive with 20+ years in personal care, specialty chemicals, and pharmaceutical product development. Previously Global Head of Hair Care Technology at Lonza and Technical & Operations Director at Perachem. Recognized innovator with 34 granted patents and 31 pending applications. Extensive expertise in R&D leadership, commercializing technology, manufacturing processes, regulatory compliance, IP strategy, and leading multicultural teams to bring disruptive technologies from concept to market.
Gal Kaspi
Operations and supply chain executive with 17+ years in pharmaceutical manufacturing and generics. General Manager at Medibrane, previously Head of End-to-End Product Strategy and Head of Third Party Make vs Buy Strategy at Teva Pharmaceuticals. Led cross-organizational business processes, product lifecycle management, and strategic decision-making across global operations. Extensive expertise in process improvement, supply chain optimization, quality systems, and driving operational excellence in pharmaceutical manufacturing.
Mike Hoang
Healthcare technology executive with 15+ years commercializing precision medicine and diagnostics platforms. Senior Director at Endpoint Health building precision-first therapeutics, previously led product management and commercialization at Roche, Life Technologies, and Beckman Coulter having launched 10+ successful products. Founded Scriptyx connecting patient outcomes data with pharma insights. Extensive expertise in strategic marketing, product lifecycle management, business development, and launching disruptive technologies.
© 2026 Collabio Collaborative Healthcare (UK Holdings) Limited. All rights reserved.
